Lux Capital

Lux Capital
Type Private
Industry Venture capital
Founded 2000
Founder(s) Peter Hébert
Robert Paull
Josh Wolfe
Headquarters New York, NY, USA
Website luxcapital.com

Lux Capital is a venture capital firm founded by Peter Hébert, Robert Paull, and Josh Wolfe[1] in 2000[2] . The firm invests in emerging technologies in the physical and life sciences.[3][4]

The firm is based in New York, with partners also located in Boston and San Diego. The Lux Capital team has built more than 20 companies from scratch.[3]

Lux's principals have been interested in developing improved methods for the treatment or remediation of nuclear waste, to assist the nuclear power industry.[3]

Lux Capital's portfolio companies include Accelergy[5], Cambrios, Cerulean Pharma[4], Crystal IS, Everspin[2], Genocea Biosciences[2][4], Kala Pharmaceuticals[4], Kereos, Kurion, Lux Research, Luxtera[3], Magen Biosciences, Molecular Imprints, Nanosys, Visterra[6], QD Soleil, SiBEAM, Silicon Clocks, Siluria Technologies, and Transphorm[7].

In April 2011, former McKinsey Senior Partner Richard N. Foster and former CIA Director James Woolsey joined Lux Capital as venture partners[8].

See also

References

  1. ^ Fickenscher, Lisa (2003). "2003 40 Under 40". Crain's New York Business Jan 27 - Feb 2, 2003: 15–31. ISSN 8756-789x. OCLC 11620213. http://mycrains.crainsnewyork.com/40under40/profiles/2003/40. 
  2. ^ a b c Eden, Scott (2009). "Nano Wunderkinds". Dealmaker December/January 2009: 35–37. ISSN 1937-304x. OCLC 132936538. http://www.scribd.com/doc/25397940/Dealmaker-Profile-Lux-Capital. 
  3. ^ a b c d Bigelow, Bruce V. (6 May 2009). "Lux Capital’s Larry Bock and Josh Wolfe Warm to Venture Deals Despite Nuclear Winter". Xconomy. http://www.xconomy.com/san-diego/2009/05/06/lux-capitals-larry-bock-and-josh-wolfe-warm-to-venture-deals-despite-nuclear-winter/. Retrieved 17 January 2010. 
  4. ^ a b c d Timmerman, Luke (23 Dec 2009). "Kala Pharmaceuticals, Stealthy New Company Tied to MIT’s Bob Langer, Gets $2M". Xconomy. http://www.xconomy.com/boston/2009/12/23/kala-pharmaceuticals-stealthy-new-company-tied-to-mits-bob-langer-gets-2m/. Retrieved 18 January 2010. 
  5. ^ Bullis, Kevin (25 Jan 2010). "Cleaner Jet Fuel from Coal". Technology Review. http://www.technologyreview.com/energy/24405/. Retrieved 1 February 2010. 
  6. ^ Lang, Michelle (12 Jul 2010). "Visterra takes in $6M VC funds, launches Singapore arm". Xconomy. http://www.masshightech.com/stories/2010/07/12/daily1-Visterra-takes-in-6M-VC-funds-launches-Singapore-arm.html. Retrieved 1 June 2011. 
  7. ^ Roushe, Wade (23 Feb 2011). "Google Ventures Leads $20M Round for Transphorm to Battle Hidden Tax in Power Conversion". Xconomy. http://www.xconomy.com/san-francisco/2011/02/23/google-ventures-leads-20m-round-for-transphorm-to-battle-hidden-tax-in-power-conversion/. Retrieved 25 February 2010. 
  8. ^ "James Woolsey and Richard Foster Join Lux Capital as Venture Partners". Business Wire. 26 April 2011. http://www.businesswire.com/news/home/20110426005086/en/James-Woolsey-Richard-Foster-Join-Lux-Capital. 

External links